483
Mark Dacey, M.D.Mark Dacey, M.D. – FDA 483, Nov 8, 2024
Record Details
Mark S. Dacey, M.D. in Denver, CO, was cited for significant deficiencies in clinical investigation practices, primarily concerning informed consent, adherence to investigational plans, and the maintenance of accurate case histories. The inspection revealed multiple instances where subjects were not properly consented, and protocols were not followed. Data discrepancies were prevalent, indicating a serious lack of oversight in clinical trial conduct.
- Office
- Denver District Office
- Person
View Company Profile
ID · 2cd18e95-9104-4701-ba2c-6c015d8daff6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.